Long-Term Follow-Up of a Randomized Phase II Study of Cisplatin/5-Fu Concurrent Chemoradiotherapy for Esophageal Cancer (KROSG0101/JROSG021)

Japanese Journal of Clinical Oncology - United Kingdom
doi 10.1093/jjco/hys112
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Oxford University Press (OUP)

Related search

A Meta-Analysis of Concurrent Chemoradiotherapy for Advanced Esophageal Cancer

PLoS ONE
Multidisciplinary
2015English

Concurrent Chemoradiotherapy Using Paclitaxel Plus Cisplatin in the Treatment of Elderly Patients With Esophageal Cancer

OncoTargets and Therapy
OncologyPharmacology
2015English

Long-Term Results of Definitive Concurrent Chemoradiotherapy Using S-1 in the Treatment of Geriatric Patients With Esophageal Cancer

OncoTargets and Therapy
OncologyPharmacology
2016English

A Long-Term Follow-Up Study of Valve Replacements.

Japanese Circulation Journal
1984English

Phase Ii Study of Concurrent Cheomoradiotherapy for Laryngeal Preservation Using Cisplatin Alone

Japanese jornal of Head and Neck Cancer
2002English

A Phase II Trial of Haptaplatin/5-Fu and Leucovorin for Advanced Stomach Cancer

Cancer Research and Treatment
Cancer ResearchOncology
2005English

Weekly Chemotherapy of 5‐Fluorouracil Plus Cisplatin Concurrent With Radiotherapy for Esophageal Squamous Cell Carcinoma Patients With Postoperative Locoregional Recurrence: Results From a Phase II Study

Oncologist
Cancer ResearchMedicineOncology
2019English

Long-Term Follow-Up of the Randomized (BIOMArCS-2) Glucose Trial

Circulation
Cardiovascular MedicinePhysiologyCardiology
2016English

A Phase II Randomized Study of Concurrent vs Sequential Letrozole With Adjuvant Hypo-Fractionated Radiotherapy: Long Term Toxicity and Survival Outcomes

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy